Zoledronic acid-induced hepatotoxicity relieved after subsequent infusions in a Chinese woman with glucocorticoid-induced osteoporosis

BACKGROUND: Zoledronic acid (ZOL) is widely used for treatment of glucocorticoid-induced osteoporosis. The most common adverse effects of ZOL treatment are post-dose symptoms. ZOL-induced hepatotoxicity has very rarely been reported. CASE REPORT: Here, we described a 50-year-old Chinese woman who ha...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Eur J Med Res
Huvudupphovsmän: Jiang, Yan, Fu, Yong, Xing, Xiao-ping, Li, Mei, Wang, Ou, Xia, Wei-bo, Meng, Xun-wu
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2015
Ämnen:
Case Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4546306/
https://ncbi.nlm.nih.gov/pubmed/26297149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40001-015-0161-1
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk